|
Dear Dartmouth Community,
Reminder to register for the Big Data in the Life Sciences Symposium - May 23rd & 24th!!
Poster Registration has been extended to 5/19
**Several Prizes Available**
Register Here: http://geiselmed.dartmouth.edu/bds/
More information below:
Please join us for this 2-day event on May 23rd & 24th in Alumni Hall. Register for either day or both!!
May 23rd- Scientific Talks
May 24th- Career Development
Poster Session registration is open to ALL students with research in related fields. Spots are limited.
Keynote Speakers:
Cathy Ball, Chief Scientific Officer, AncestryDNA, LLC
Dave Jensen, Managing Director, CareerTrax, Inc.
Presented by The Burroughs Wellcome Fund (BWF) Big Data Training Program
Contributing Sponsors:
Office of the Provost
School of Graduate & Advanced Studies
Geisel’s Office of the Dean
Quantitative Biology Research Institute (QBRI)
Department of Molecular and Systems Biology
Center for Molecular Epidemiology
Quantitative Biomedical Sciences (QBS)
Questions?? Please contact Shaniqua Jones ([log in to unmask])
fyi... these GRAD Alums will be speaking...What an opportunity to network!
Sarah Pendergrass, PhD
Dr. Sarah Pendergrass is an Assistant Professor in the Biomedical and Translational Informatics Program of Geisinger Health System. Dr. Pendergrass is a Genetic Bioinformatician and a nationally recognized expert in Phenome-Wide Association Studies (PheWAS), an approach investigating the association between genetic variation and wide range of phenotypic variables. As part of the MyCode Community Health Initiative, the Population Architecture using Genomics and Epidemiology (PAGE) network and the Electronic Medical Records and Genomics (eMERGE) consortia, and the Aids Clincal Trials Group (ACTG) she has published over ten papers on methods and applications for PheWAS. She also has expertise in the development of bioinformatics tools for rare variant analysis (BioBin) and for data visualization (PhenoGram, PhenoGram-Genie, Synthesis-View, and PheWAS-View). Through her PhD she has expertise in gene-expression analyses and bioinformatics, with projects leveraging the complexity of gene-expression data for biomarker and biological discovery for the disease Systemic Sclerosis. Her masters work in Biomedical Engineering, and undergraduate degree in Physics, have provided her with additional technical and analytical expertise for complex data-driven projects.
Shinichiro Fuse, PhD
Shinichiro Fuse, PhD, joined MPM Capital as Principal in 2016. Prior to joining MPM, Shin was Director of Business Development at bluebird bio. At bluebird, he played an instrumental role in executing and managing key industry and academic partnerships in the fields of cell and gene therapy, cancer immunotherapy, and genome editing, including partnerships with Five Prime Therapeutics, Seattle Children's Research Institute, and the acquisition of Pregenen.
Previously, he was an Engagement Manager at Campbell Alliance (inVentiv Health Consulting), where he worked with clients in the life science industry to evaluate business development opportunities, develop commercialization strategies, and support new product launches. Prior to joining Campbell Alliance, Shin was an Associate at PureTech Ventures, where he focused on venture creation activities in the microbiome space and technology due diligence. Shin also serves as a columnist and contributing writer for Nikkei Biotech, the leading journal covering the biotech industry in Japan.
Shin received his PhD in Microbiology and Immunology from Dartmouth College, a MS in Biomedical Science from the University of Tokyo, and a B.Eng. in Applied Chemistry from Keio University in Japan.
Yolanda C. Nesbeth, Ph.D
Yolanda C. Nesbeth, Ph.D. is a Director at Celdara Medical and the Site-Head for the Washington DC office, where she leads multiple internal therapeutic development programs, in addition to managing a CLIA certified lab providing molecular diagnostics for systemic sclerosis patients, clinicians and drug developers. Yolanda previously worked as a Consultant with Clarion Healthcare, providing strategic advice to pharmaceutical and biotechnology companies on key scientific and commercial matters related to drug development, promotion and regulatory processes. In this capacity, she evaluated the attractiveness of hundreds of products, resulting in comprehensive recommendations for in-licensing, purchase or partnering, and conducted competitive assessments and situational analyses to inform corporate strategy within respiratory, infectious disease and various oncology markets. At Celdara Medical, Yolanda continues to provide strategic support and performs diligence on numerous opportunities for the Celdara Medical pipeline. Yolanda received her Ph.D. in Microbiology and Immunology from Dartmouth Medical School. During her graduate career she developed therapeutic cell-based technologies and immunotherapies against ovarian cancer. She was the Ph.D. Class Marshal and Graduate Student Speaker at Dartmouth Medical School Commencement, a Kauffman Fellow Finalist (1 of 11 worldwide in healthcare), an Albert J. Ryan Fellow and a winner of the University of the West Indies Open Scholarship (highest award offered). Yolanda serves as a Reviewer for NIH and DOD study sections and is a member of various biotech organizations. An avid tennis player, she has served as Captain of her recreational and USTA tennis league teams, and volunteers with various organizations serving children and youth.
|